1 25 May 2020 Subject: Notification on Resolution of the Board of Directors’ Meeting No. 5/2020, Change of Directors and Directors’ Power, Entering into Connected Transaction, Entering into Transaction on Acquisition of Assets and Determination of the 2020 Annual General Meeting of Shareholders To: Director and Manager The Stock Exchange of Thailand Enclosure 1. Information Memorandum on the Acquisition of Assets (Schedule 1) and the Entry into Connected Transaction of Nation Broadcasting Corpor...
คุคลที่ทําประโยชนใหแก issuer และผูถือหุนของ issuer ในระยะยาว เชน ตวัแทนขายประกนัชีวิตที่ขายสินคาเฉพาะใหแก issuer (exclusive agent) และ มีผลงานจากการขายสินคาอยางตอเนื่อง (active agent) เปนต
-Eleven stores nationwide. After You open a concept store in Chinatown with a unique store design and exclusive menu items In August 2024, the Company opened a new After You branch in Chinatown, located on
receiving of shares in SUTG at 66.00 per cent the valuation can be summarized as per below: Equity Value SUTG (THB mn) Discounted Cash Flow Price-to-Earning per share 700 1,118 As shown above, the discounted
Entire Business Transfer Plan. In this regards, the receiving of shares in SUTG at 66.00 per cent the valuation can be summarized as per below: Equity Value SUTG (THB mn) Discounted Cash Flow Price-to
total 44.96 million Bath, inventory in amount 85.09 million Baht, and has increased the valuation adjustment of the available for sale of investment in amount 100.97 million Baht, decreased investment in
Baht ,decreased trade account receivables, receivables from related companies increased total 66.88 million Bath and inventory increased in amount 135.77 million Baht, the valuation adjustment of the
/ Fund Supervisor, and requirements relating to Approval, Valuation, and Operational Matters และ Part II : The Product Restrictions of Qualifying CIS ซึ่งอยู่ใน Appendix C : Standards of Qualifying CIS ของ
: Qualifications of the CIS operator, Trustee/Fund Supervisor, and requirements relating to Approval, Valuation, and Operational Matters and Part II : The Product Restrictions of Qualifying CIS as prescribed in